Sante Atlantique

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Colorectal cancer1 trial

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Not yet recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Glaxosmithkline Research & Development Limited2 trials
• Centre Hospitalier Regional Universitaire1 trial
• GlaxoSmithKline1 trial

Running trials

• Not yet recruiting

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· Phase 3· Glaxosmithkline Research & Development Limited· Source

• Not yet recruiting

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· Phase 3· Glaxosmithkline Research & Development Limited· Source

• Recruiting

  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  NCT07221188· Phase 3· GlaxoSmithKline· Source

• Recruiting

  FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage

  NCT05168839· Phase 4· Centre Hospitalier Regional Universitaire· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)3 recruiting
• Colorectal cancer1 recruiting